Encore Medical
VS
Shionogi

Biotech comparison — funding, valuation, and investors, sourced from Value Add Pulse coverage.

EM
Encore Medical

Encore Medical develops transcatheter septal occlusion devices to repair structural heart defects like patent foramen ovale (PFO).

2 Pulse stories
S
Shionogi

Japanese pharmaceutical company developing prescription drugs, infectious disease therapies, and specialty medicines, including a former sleep apnea drug joint venture with Apnimed.

2 Pulse stories
Total RaisedNot disclosed
Last ValuationNot disclosed
Biotech
Sector
Biotech
2017
Founded
1878
Eagan, Minnesota
HQ
Osaka, Japan
Public (EMI)
Status
Public (4507.T)
Encore Medical investors
No investors on record.
Shionogi investors
No investors on record.

Data from Value Add Pulse coverage and company research — see the full threads for Encore Medical and Shionogi.